Apogee Therapeutics (APGE) news
Recent news
Soros adds AEP, NBIS, APGE, DBRG, TMHC in 2Q: 13F
Billionaire investor George Soros' family office, Soros Fund Management, added several new positions in the second quarter of 2026, according to a recent 13F filing submitted to the U.S. Securities and Exchange Commission. Among the newly acquired stocks were American Electric Power (AEP), Northern…
AInvest Wire · Aug 14, 2026Apogee Therapeutics, Inc.: Truist Securities raises target price to $135 from $81
AInvest Wire · Aug 13, 2026Apogee Therapeutics, Inc.: BTIG cuts to neutral from buy
Apogee Therapeutics, Inc. (NASDAQ: APGE) recently experienced a downgrade in its analyst rating from BTIG Research. On January 5, 2026, BTIG cut its rating on the stock to "Hold" from "Buy," while maintaining a price target of $128 . This adjustment follows a series of positive developments related…
AInvest Wire · Aug 12, 2026Apogee Therapeutics Q2 2026 net loss $85.90 mln
Apogee Therapeutics, Inc. (Nasdaq: APGE) reported a net loss of $85.90 million for the second quarter of 2026, according to its financial results. This represents a significant increase from the net loss of $74.1 million in the first quarter of 2026 and $55.3 million in the same period of 2025. The…
AInvest Wire · Aug 10, 2026AbbVie seeks at least $8 billion in debt to fund Apogee deal - Bloomberg News
AbbVie Inc. (NYSE: ABBV) is reportedly seeking at least $8 billion in debt financing to support its $10.9 billion acquisition of Apogee Therapeutics, according to Bloomberg News. The deal, announced on June 22, 2026, involves acquiring all outstanding shares of Apogee for $135.11 per share in cash,…
AInvest Wire · Aug 4, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.